Robert Davidson - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Robert Davidson's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Robert Davidson
Verified
Editor-in-Chief, U.S. Pharmacist
New Jersey
Beats
Content
By Robert Davidson Verified| U.S. Pharmacist Verified US Pharm. 2025;50(4):1. On a recent warm afternoon, my wife and I were turned away from a favorite reservoir and trail system in northwest New Jersey due to the detection of avian flu in dead or sick birds in the area. The site, the notice read, would be closed until further notice.
By Robert Davidson Verified| U.S. Pharmacist Verified US Pharm. 2025;50(3):4. Vertex Pharmaceuticals, Inc., recently announced that the FDA approved suzetrigine (Journavx), an oral, nonopioid, highly selective pain signal inhibitor for the treatment of adults with moderate-to-severe acute pain. In clinical trials, suzetrigine was shown to be an effective, well-tolerated medication without evidence of addictive potential, the manufacturer said.
By Robert Davidson Verified| U.S. Pharmacist Verified US Pharm. 2025;50(4):1. On a recent warm afternoon, my wife and I were turned away from a favorite reservoir and trail system in northwest New Jersey due to the detection of avian flu in dead or sick birds in the area. The site, the notice read, would be closed until further notice.
Company Info
U.S. Pharmacist
U.S. Pharmacist is the leading clinically-focused monthly pharmacy publication providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice.
'+1 877-529-1746
Founded: 1975